Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Borderline personality disorder
Bremelanotide use in patients with renal impairment use in patients with hepatic impairment
Brexpiprazole Antipsychotics - minimum effective doses Psychotropics in overdose Relative adverse effects - a rough guide Equivalent doses Quick reference for licensed maximum doses
British Association for Psychopharmacology dementia recommendations catatonia
Buccal administration, antipsychotics
bulimia nervosa (BN) 794-795 comorbid depression NICE guidelines
Buprenorphine
Bupropion (amfebutamone) 145 attention deficit hyperactivity disorder in adults borderline personality disorder butyrophenones, in overdose Clozapine-induced hypersalivation in overdose nicotine addiction adverse effects binge eating disorder buspirone, in overdose clinical effectiveness contraindicated in anorexia nervosa in pregnancy preparations and doses
Caffeine
Calcium in blood, psychotropic agent effects
Cannabis/cannabinoids Drugs of misuse - a summary Negative symptoms Tics and Tourette's syndrome in children and adolescents Drug treatment of depression Substance misuse in pregnancy
Capacity and consent covert administration of medicines in food and drink mental health act assessment in older people learning difficulties right not to take medication
Carbamazepine: prescribing and monitoring
carbohydrate-deficient transferrin (CDT), psychotropic agent effects
Cardiac death
Cardiac effects antidepressants torsades de pointes/QT interval prolongation risk with methadone drug-induced excited states
Cardiac malformation in infants, maternal mental health problems and lithium
Cardiovascular agents, psychiatric adverse effects
Cardiovascular effects, antiretrovirals
Care homes and environments, learning difficulties
Cariprazine bipolar disorder in overdose Relative adverse effects - a rough guide Antipsychotics - minimum effective doses Equivalent doses Quick reference for licensed maximum doses
Catatonia associated psychiatric and medical conditions algorithm for treatment of catatonic stupor Catatonia in schizophrenia treatment ECT treatment sub-types
Approximate estimates of relative incidence and severity of adverse effects
Aripiprazole 2-month ready-to-use initiation regimen
Aristada
A suggested reduction regimen for buprenorphine
Ataxia, alcohol effects
attention deficit hyperactivity disorder (ADHD)
Atypical eating disorders
Avoid contra-indicated drugs even if not planning pregnancy